Nektar Therapeutics Announces Strategic Reprioritization and Cost Restructuring Plan
-- Pipeline focus will prioritize programs in immunology, including REZPEG and several immunology research programs -- -- Development of NKTR-255 in diffuse...
Source: prnewswire.com